TRI-SCORE has recently been introduced as a dedicated risk score for tricuspid valve surgery. Aims This study analyzes the predictive performance of TRI-SCORE following transcatheter edge-to-edge tricuspid valve repair. Methods 180 patients who underwent transcatheter tricuspid val...
Variations of V-V support include (a) the use of a dual-lumen cannula inserted across the tricuspid valve into the pulmonary artery that supports RV function in addition to gas exchange (also called Oxy-RVAD) or (b) other configurations (a right atriopulmonary or right-to-left atrium ...
Transcatheter mitral valve replacement (TMVR) is the subject of intense investigation, and tricuspid valve interventions in high-surgical-risk patients are being developed. Collectively, these advances have led to an increasing number of treatment options, lower thresholds for and earlier timing of ...
and superior to EuroSCORE II (AUC 56.6% and 64.4%, respectively) and STS-Score (AUC 61.0% and 59.0%, respectively).TRI-SCORE is a valuable tool for prediction of mortality after transcatheter edge-to-edge tricuspid valve repair and its performance is superior to EuroSCORE II and STS-Score...
Objective— The incidence of intravenous drug associated (IVDA) Tricuspid Valve (TV) endocarditis in the United States is rapidly increasing. Our goal was to evaluate the outcomes of isolated TV operations using the Society of Thoracic Surgeon (STS) Adult Cardiac Surgical Database. Methods— From...
Median Score 7 to 9: Appropriate test for specific indication (test is generally acceptable and is a reasonable approach for the indication). An appropriate option for management of patients in this population due to benefits generally outweighing risks; an effective option for individual care plans...
There was no association of severe PPM with stroke or quality-of-life score at 1 year. Conclusions Severe PPM after TAVR was present in 12% of patients and was associated with higher mortality and HF rehospitalization at 1 year. Further investigation is warranted into the prevention of severe...
Compared with patients with tricuspid AS, bicuspid AS patients were younger (77.5 vs. 84.88 years, p < 0.001), less likely to have underlying conduction system disease (21.53% vs. 29.26%, p=0.0707), tended to have a lower Euro Score II (5.71 vs. 6.70, p=0.07) and had lower STS ...
Methods: Data from the Society of Thoracic Surgeons/American College of Cardiology TVT (Transcatheter Valve Therapy) Registry for patients undergoing TAVR with CoreValve, Evolut R, or Evolut PRO valves to treat tricuspid aortic stenosis between January 2014 and September 2017 were obtained. Patient ...